Intermittent COVID-19 symptoms likely just one, long infection — and that's good news

A pharmacist gives Jennifer Haller (left) the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle on March 16.
Ted S. Warren | AP
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.